Milestone Pharmaceuticals

graphic of a paper airplane labeled plan A crashing while a rocket labeled plan B takes off

Biotech

Milestone resubmits NDA, Aldeyra readies 2nd chance filing

Milestone Pharmaceuticals has resubmitted a new drug application to the FDA, with Aldeyra readying a similar ask for the second half of the year.

Max Bayer Mar 28, 2024 10:40am

heart art heart failure genes

After 2020 flop, Milestone's arrhythmia spray hits in phase 3

Oct 17, 2022 6:00am